Tissue distribution of bacteriochlorin a labelled with 99mTc-pertechnetate in hamster Greene melanoma. 1993

J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
Department of Ophthalmology, State University of Leiden, The Netherlands.

Bacteriochlorin a (BCA), a new photosensitizer for photodynamic therapy, was labelled with 99mTc-pertechnetate following a method for the irreversible coupling of 99mTc-pertechnetate to proteins. Biodistribution studies were conducted in male Syrian Golden hamsters with hamster Greene melanoma implanted s.c. on both sides of the abdomen. After i.v. administration of 99mTc-pertechnetate-labelled BCA 17 tissue and fluid samples were analysed at time intervals ranging from 1 to 24 h. Technetium-labelled BCA showed a pronounced affinity for tissues belonging to the reticuloendothelial system. Peak activities, 1 h post-injection, were distributed as follows: lung, liver, spleen, urine > small intestine, kidney, blood, heart, stomach, large intestine > thyroid, tumour, bone, skin, muscle, eye >> brain. It is concluded that the technetium-labelled photosensitizer BCA does not accumulate selectively in neoplastic tissue.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D008297 Male Males
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D011166 Porphyrins A group of compounds containing the porphin structure, four pyrrole rings connected by methine bridges in a cyclic configuration to which a variety of side chains are attached. The nature of the side chain is indicated by a prefix, as uroporphyrin, hematoporphyrin, etc. The porphyrins, in combination with iron, form the heme component in biologically significant compounds such as hemoglobin and myoglobin. Porphyrin
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013670 Sodium Pertechnetate Tc 99m A gamma-emitting radionuclide imaging agent used for the diagnosis of diseases in many tissues, particularly in the gastrointestinal system, cardiovascular and cerebral circulation, brain, thyroid, and joints. Pertechnetate Sodium,Tc 99m-Pertechnetate,Technetium Tc 99m Pertechnetate,99Tc-Pertechnetate,99TcmO4,99mTcO4,Pertechnetate,Technetium Pertechnetate,Technetium Tc 99m O(4),Technetium-99mTc-pertechnetate,99Tc Pertechnetate,99m-Pertechnetate, Tc,Pertechnetate, Technetium,Sodium, Pertechnetate,Tc 99m Pertechnetate,Technetium 99mTc pertechnetate
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions

Related Publications

J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
July 2003, Journal of submicroscopic cytology and pathology,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
March 1974, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
July 1975, International journal of nuclear medicine and biology,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
August 1977, Radiology,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
December 1973, The Yale journal of biology and medicine,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
July 1979, Clinical nuclear medicine,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
October 2004, Melanoma research,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
April 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
June 1994, Kaku igaku. The Japanese journal of nuclear medicine,
J J Schuitmaker, and R I Feitsma, and J G Journée-De Korver, and T M Dubbelman, and E K Pauwels
September 1987, The British journal of ophthalmology,
Copied contents to your clipboard!